Series
Pulmonary and airways
Status
Published
Date
Number of report
095
Mechanical ventilation
Ask the expert
The report presents a summary of reimbursement situation for mechanical ventilation in European countries.
Sample pages are provided for an older version of the report. Before delivery to the client, the report is updated to the current state (e.g., 2022 coding, tariffs, and policy considerations).
The following clinical indications will be considered:
- Acute community-acquired viral pneumonia complicated with acute respiratory failure;
- Severe sepsis due to acute community-acquired viral pneumonia with multiorgan failure (cardiac, respiratory and renal);
- Acute hemorrhagic stroke with the development of coma.
The only reimbursement within public / statutory health insurance systems is considered.
Report includes essential information about reimbursement and national funding, including:
- Brief overview of reimbursement system for medical devices
- Procedure coding for technology
- Diagnosis coding
- Payment mechanism for technology
- Reimbursement tariffs for technology
- Restrictions in indications or scenarios for use of technology
- Policy considerations by payers and policy-makers about technology
Reimbursement information is provided for the following geographies:
- Austria
- Belgium
- Czech Republic
- Denmark
- England (UK)
- Finland
- France
- Germany
- Hungary
- Italy
- Netherlands
- Norway
- Romania
- Russia
- Sweden
- Switzerland
- Turkey
Manufacturers of devices for mechanical ventilation include:
- Air Liquide (Monnal, CPX Care, eXtend, Orion)
- Airon Mindray (E and SV Series)
- Allied Healthcare (EPV200)
- Breas Medical (Vivo)
- Dräger (Savina, Evita, Oxylog)
- Fisher & Paykel (F&P 850)
- FLU (FEILON) (VG70 Invasive Ventilator)
- GE Healthcare (CARESCAPE R860)
- Getinge (Servo-u, Servo-air, Servo-I, Servo-s)
- Hamilton Medical (HAMILTON-C1, HAMILTON-S1, HAMILTON-G5, HAMILTON-C3)
- Medtronic (Puritan Bennett, Newport)
- Philips Healthcare (Respironics BiPAP V30 Auto, Respironics V60, Respironics Trilogy 202, Respironics NM3, Respironics Respi-Link, Trilogy EV300)
- ResMed (Astral, Stellar, Lumis)
- Smiths Medical (PNEUPAC, PORTEX)
- Schiller (GRAPHNET, GRAPHNET ADVANCE, AQUILON)
- Teleflex (ConchaSmart, ISO-Gard, Comfort Flo)
- Vyaire Medical (Avea CVS, BELLAVISTA)
- WEINMANN (MEDUMAT)
- Zoll Medical (Z Vent)
Table of content is not available at the moment. Report is still ongoing.
27
May 2022
In April 2022, the National Institute for Health Research (NIHR) in England released two MedTech-related reports in its Health Technology Assessment (HTA) Journal, which concerned uterine artery embolization versus myomectomy for premenopausal women with uterine fibroids and supraglottic airway device versus tracheal intubation in the initial airway management. HTA Journal publishes research reports on the effectiveness, costs, and broader impact of health technologies for those who use, manage, and provide care in the NHS and informs National Institute for Health and Care Excellence (NICE) guidance.
Read more08
Oct 2021
In September 2021, the National Institute for Health and Care Excellence (NICE) published three new Interventional Procedure Guidance (transapical transcatheter mitral valve-in-valve implantation for a failed surgically implanted mitral valve bioprosthesis, transapical transcatheter mitral valve-in-ring (TMVIR) after failed annuloplasty for mitral valve repair, and lateral elbow resurfacing for arthritis), and two new Medtech Innovation Briefings (Carnation Ambulatory Monitor, OrganOx metra for liver transplant). Also, one clinical guideline was updated.
Read more29
Sep 2021
In August 2021, the National Institute for Health and Care Excellence (NICE) published three new Interventional Procedure Guidance (magnetic resonance therapy for knee osteoarthritis, laparoscopic removal of uterine fibroids with power morcellation, hysteroscopic mechanical tissue removal for uterine fibroids), and six new Medtech Innovation Briefings (PLASMA system with button electrode, Immunoscore, MMprofiler, Patient Status Engine, lung texture analysis, Colli-Pee). Also, five clinical guidelines were published.
Read more12
Nov 2020
In late October 2020, the BfArM (Federal Institute for Drugs and Medical Devices) has published the final version of the OPS 2021 (Operation and Procedure Keys) system. The OPS, together with the ICD-10-GM (International Statistical Classification of Diseases and Related Health Problems, 10th revision, German Modification), forms the basis for the reimbursement systems in outpatient and inpatient care.
Read more29
Jun 2020
On June 23, 2020, the Swiss Federal Office of Public Health (FOPH) announced several changes in the coverage of benefits that will take place soon. They regard transcatheter aortic valve implantation (TAVI), adjustments in the List of Aids (EMAp/MiGeL) (including reimbursement for CPAP devices and mechanical ventilation at home, and adjustments in the List of Analyses (AL/EA).
Read more